This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Founded in 1931 and headquartered in Northbrook, Illinois, The Allstate Corporation is the third-largest property-casualty (P&C) insurer and the largest publicly-held personal lines carrier in the U.S. The company also provides a range of life insurance and investment products to its diverse customer base. It provides insurance products to approximately 16 million households through more than 12,000 exclusive agencies and financial specialists in the U.S. and Canada.
Allstate Q2 Earnings Beat Estimates on Strong Premium Growth
by Zacks Equity Research
ALL posts a massive Q2 earnings beat as premium growth, strong investments and lower costs drive a sharp profit surge.
Allstate (ALL) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Allstate (ALL) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Allstate (ALL) Q2 Earnings Top Estimates
by Zacks Equity Research
Allstate (ALL) delivered earnings and revenue surprises of +78.92% and -2.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
What Should You Do With Berkshire Stock Ahead of Q2 Earnings?
by Tanuka De
BRK.B eyes revenue growth in Q2 on insurance strength and investment gains, but earnings may dip slightly year over year.
Allstate to Report Q2 Earnings: Can Auto Brand Strength Save the Day?
by Zacks Equity Research
ALL's Q2 earnings are likely to witness rising auto underwriting income and premium gains, facing cost headwinds.
Palomar (PLMR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Palomar (PLMR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights Berkshire Hathaway, Progressive, Chubb, Travelers Companies and Allstate
by Zacks Equity Research
BRK.B, PGR, CB, TRV and ALL are positioned for growth as tech adoption, pricing power and underwriting drive P&C momentum.
5 P&C Insurance Stocks to Watch Amid Increased Digitalization
by Tanuka De
Zacks Property and Casualty Insurance players like BRK.B, PGR, CB, TRV and ALL are likely to benefit from digitalization and catastrophes that drive policy renewal rate and pricing.
Allstate (ALL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Allstate (ALL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Allstate (ALL) Laps the Stock Market: Here's Why
by Zacks Equity Research
Allstate (ALL) closed at $197.43 in the latest trading session, marking a +2.34% move from the prior day.
Allstate (ALL) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes? Let's find out.
Allstate (ALL) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
The latest trading day saw Allstate (ALL) settling at $196.2, representing a +1.48% change from its previous close.
Allstate Finalizes Group Health Divestiture for $1.25 Bn
by Zacks Equity Research
ALL concludes the sale of its Group Health business to Nationwide, netting a roughly $500 million book gain and sharpening focus on core operations.
ALL or KNSL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ALL vs. KNSL: Which Stock Is the Better Value Option?
CNA Stock Trading at a Discount to Industry at 1.22X: Time to Hold?
by Zacks Equity Research
CNA Financial is poised to gain from solid retention, favorable renewal premium change and new business growth across Specialty, Commercial and International segments.
Can Lemonade's Reinsurance Renewal Boost Financial Flexibility?
by Zacks Equity Research
LMND reduces reliance on reinsurance to boost margins, strengthen cash flow, and drive growth across U.S. and European markets.
PLMR Outperforms Industry, Trades at Premium: How to Play the Stock
by Zacks Equity Research
Palomar Holdings is poised to gain from its fee-based platform, rising crop premiums, Surety expansion and debt-free balance sheet backed by strong reinsurance strategy.
Are Investors Undervaluing Allstate (ALL) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Allstate (ALL) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Allstate (ALL). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Allstate (ALL) Rises Higher Than Market: Key Facts
by Zacks Equity Research
Allstate (ALL) reached $201.31 at the closing of the latest trading day, reflecting a +2.84% change compared to its last close.
Progressive Stock Falls 5% in 3 Months: Should You Buy the Dip?
by Tanuka De
PGR shares decline 5% but strong underwriting, digital gains, and analyst upgrades point to long-term upside potential.
Allstate (ALL) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
Allstate (ALL) reached $196.05 at the closing of the latest trading day, reflecting a -1.15% change compared to its last close.
PGR's Commercial Lines Fuels Growth: Can it Sustain the Momentum?
by Tanuka De
PGR's Commercial Lines now drive 14% of premiums, boosting margins and helping diversify beyond personal auto.
Allstate (ALL) Declines More Than Market: Some Information for Investors
by Zacks Equity Research
In the most recent trading session, Allstate (ALL) closed at $195.67, indicating a -1.27% shift from the previous trading day.
TRV Outperforms Industry, Trades at Premium: How to Play the Stock
by Zacks Equity Research
Travelers' momentum in renewal rate improvements, high retention levels and increased new business are likely to sustain its earnings growth.